Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gain-of-function genetic perturbationssimultaneouslyacross500 barcoded cancer cell lines

ABSTRACT: Gain-of-function genetic perturbationssimultaneouslyacross500 barcoded cancer cell lines

PROVIDER: PRJNA997999 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25405900.fastq.gz	Fastqsanger.gz
	SRR25405901.fastq.gz	Fastqsanger.gz
	SRR25405902.fastq.gz	Fastqsanger.gz
	SRR25405903.fastq.gz	Fastqsanger.gz
	SRR25405904.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 66

Similar Datasets

TLR7 gain-of-function genetic variation causes human lupus

Project description:TLR7 gain-of-function genetic variation causes human lupus

| PRJNA804244 | ENA

Gain-of-function genetic alterations of G9a drive oncogenesis

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis

| PRJNA614536 | ENA

Gain-of-function genetic perturbationssimultaneouslyacross500 barcoded cancer cell lines

Project description:Using thisapproach, wequeriedthe pan-cancer vulnerability landscape upon activating 10key pathway nodes, revealing selectiveactivation dependenciesof MAPK and PI3K pathwaysassociatedwith specific biomarkers

2023-07-27 | GSE238126 | GEO

Gain-of-function genetic alterations of G9a drive oncogenesis I

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis I

| PRJNA614522 | ENA

Gain-of-function genetic alterations of G9a drive oncogenesis II

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis II

| PRJNA614541 | ENA

Strain abundance assay of barcoded DAmP loss of function S. cerevisiae strains exposed to various compounds

Project description:The ability to perform complex bioassays in parallel enables experiments otherwise impossible due to throughput and cost constraints. By way of example, highly parallel chemical-genetic screens using pooled collections of thousands of defined Saccharomyces cerevisiae gene deletion strains are feasible because each strain is barcoded with unique DNA sequences. It is, however, time consuming and expensive to individually barcode individual strains. To provide a simple and general method of barcoding yeast collections, we built a set of donor strains, called Barcoders, with unique barcodes that can be systematically transferred to any S. cerevisiae collection. We applied this technology by generating a collection of barcoded DAmP (Decreased Abundance by mRNA Perturbation) loss-of-function strains comprising 87.1% of all essential yeast genes. This test collection validates both the Barcoders and the DAmP collection as useful tools for genome-wide chemical genetic assays.

2008-07-03 | E-MEXP-1671 | biostudies-arrayexpress

Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions

Project description:<p>Solute carrier (SLC) transporters control fluxes of nutrients and metabolites across membranes and thereby represent a critical interface between the microenvironment and cellular and subcellular metabolism. Because of substantial functional overlap, the interplay and relative contributions of SLCs in response to environmental stresses remain poorly elucidated. To infer functional relationships between SLCs and metabolites, we developed a strategy to identify SLCs able to sustain cell viability and proliferation under growth-limiting concentrations of essential nutrients. One-by-one depletion of 13 amino acids required for cell proliferation enabled gain-of-function genetic screens using a SLC-focused CRISPR/Cas9–based transcriptional activation approach to uncover transporters relieving cells from growth-limiting metabolic bottlenecks. Among the transporters identified, we characterized the cationic amino acid transporter SLC7A3 as a gene that, when up-regulated, overcame low availability of arginine and lysine by increasing their uptake, whereas SLC7A5 was able to sustain cellular fitness upon deprivation of several neutral amino acids. Moreover, we identified metabolic compensation mediated by the glutamate/aspartate transporters SLC1A2 and SLC1A3 under glutamine-limiting conditions. Overall, this gain-of-function approach using human cells uncovered functional transporter-nutrient relationships and revealed that transport activity up-regulation may be sufficient to overcome environmental metabolic restrictions.</p>

2022-09-20 | MTBLS4268 | MetaboLights

Gain-of-function genetic alterations of G9a drive oncogenesis II

Project description:Epigenetic regulators, when genomically altered, may become driver oncogenes that mediate otherwise unexplained pro-oncogenic changes lacking a clear genetic stimulus, such as activation of the WNT/b-catenin pathway in melanoma. This study identifies previously unrecognized recurrent activating mutations in the G9a histone methyltransferase gene, as well as G9a genomic copy gains in ~26% of human melanomas, which collectively drive tumor growth and an immunologically sterile microenvironment beyond melanoma. Furthermore, the WNT pathway is identified as a key tumorigenic target of G9a gain-of-function, via suppression of the WNT antagonist DKK1. Importantly, genetic or pharmacologic suppression of mutated or amplified G9a using multiple in vitro and in vivo models demonstrate that G9a is a druggable target for therapeutic intervention in melanoma and other cancers harboring G9a genomic aberrations.

2020-04-20 | GSE147427 | GEO

Gain-of-function genetic alterations of G9a drive oncogenesis I

2020-04-20 | GSE147419 | GEO

Twist1 gain-of-function studied in 2 normal gastric fibroblast lines

Project description:Primary human gastric normal fibroblast cultures (NL14 and NL32, repectivley) were establised from 2 gastrectomy specimens. Enforced expression (gain-of-function effect) of Twist1 in 2 gastric normal fibroblasts (NL14 and NL32) showed candidate target genes and CAF markers upregulated by Twist1. Experiment design: 2 normal gastric fibroblasts (NL14 and NL32) were establised and studied for Twist1 gain-of-function.

2014-10-28 | E-GEOD-62739 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data